Biotechnology: Europe’s next ‘hot potato’

By |oktober 16th, 2019|Biotechnology, GMO directive, GMOs, new plant breeding techniques, News|

The discussion over the future of biotechnology in Europe heated up after the EU Court ruled in July last year that gene editing should, in principle, fall under the GMO Directive. In this special report, EURACTIV will focus on the future of biotech...

Komentarji so izklopljeni za Biotechnology: Europe’s next ‘hot potato’

Andriukaitis: 100-year old production models cannot achieve food sustainability

By |oktober 16th, 2019|Biotechnology, FAO, GMO, GMO directive, GMOs, ifoam, new plant breeding techniques, News, plant breeding, Vytenis Andriukaitis|

According to the UN, the amount of food produced globally needs to double to feed a rising world population. Policymakers are poring over ways to ensure the sustainability of food systems while emerging new technologies, promising to tackle climate cha...

Komentarji so izklopljeni za Andriukaitis: 100-year old production models cannot achieve food sustainability

Has Europe lost the new biotechnology battle?

By |julij 10th, 2019|Biotechnology, genome research, GMO directive, GMOs, News|

The EU's rules on GMOs risk stifling innovation in biotechnology and could lead to China and the US increasing their patent domination, writes Marcel Kuntz.

Komentarji so izklopljeni za Has Europe lost the new biotechnology battle?

EU Bioeconomy 2.0– Cultivating a home grown success

By |marec 8th, 2018|bioeconomy, biomass, Biotechnology, digitisation, News|

Barely six years old, the EU’s Bioeonomy Strategy, currently under revision, is slowly but surely propagating green shoots of sustainable economic recovery in innumerable and unexpected ways, writes Joanna Dupont.

Komentarji so izklopljeni za EU Bioeconomy 2.0– Cultivating a home grown success

FAO official: GMOs not needed but we should be open to biotechnologies

By |september 26th, 2017|agroecology, Biotechnology, FAO, Food and Agriculture Organization, News, United Nations|

The requirements of food production can be met without GMOs but we should not eliminate the broader benefits that biotechnologies can provide, Daniel Gustafson told EURACTIV.com in an interview.

Komentarji so izklopljeni za FAO official: GMOs not needed but we should be open to biotechnologies

Amsterdam wants to revive talks on new plant breeding techniques

By |september 11th, 2017|Biotechnology, GMOs, new plant breeding techniques, News|

The Netherlands believes the new plant breeding techniques should not come under the GMO legislation as they are as safe as traditional breeding. It also insists that a discussion on the issue should be launched soon, even before the EU Court rules on ...

Komentarji so izklopljeni za Amsterdam wants to revive talks on new plant breeding techniques

IMI chief: ‘We need to learn how to share data in a safe and ethical manner’

By |april 7th, 2017|alzheimer's, Antimicrobial resistance, asthma, biomedicines, Biotechnology, cancer, medicines, News, rare diseases, World Health Organisation|

Ethicists, humanists, lawyers and patients should come together to understand the risk of data in healthcare and whether patients are willing to take that risk, Pierre Meulien told EURACTIV.com.

Komentarji so izklopljeni za IMI chief: ‘We need to learn how to share data in a safe and ethical manner’

Europe’s biotechnology potential hindered by investment fears

By |april 6th, 2017|Biotechnology, Innovation, investment, investment climate, News, university|

In terms of pure biotechnology, Europe has embraced innovation. However, it cannot compete with the US yet because it cannot drive private investment in the field, as well as open up the market to new products, a pharmaceutical executive told EURACTIV....

Komentarji so izklopljeni za Europe’s biotechnology potential hindered by investment fears

Commission sees biotech as ‘integral part’ of EU healthcare

By |marec 15th, 2017|Biotechnology, cancer, diabetes, Hepatitis, medical research, medical technology, News|

Biotechnology-derived medicinal products are fully part of EU healthcare but there are still many unknowns which call for adequate controls, the European Commission told EURACTIV.

Komentarji so izklopljeni za Commission sees biotech as ‘integral part’ of EU healthcare